AYTU Archives - Page 4 of 5 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: VTVT New Highs & More

vTv Therapeutics, Inc. VTVT

We’ve been closely tracking VTVT since including it our report on Tuesday morning as a bottom play. As we mentioned yesterday, the timing was essentially perfect. It took off on Tuesday, and yesterday that run persisted just as we suggested it may.

The stock traded in a range from 1.24 to a new high of 2.67 yesterday, representing an intraday move of 115% From Tuesday’s low of .79 the stock has registered a two-day upswing of 238% and has easily been the NASDAQ’s top play of the week.

Onconova Therapeutics, Inc. ONTX

Speaking of bottom plays, we’re always searching for the next heavily oversold stock, and we’ve got a candidate to bring forth today in ONTX. As you can plainly view on the chart snapshot below, the stock has been heavily sold off, and the RSI is definitely giving off that heavily oversold signal.

The last time that happened the stock did mount an appreciable recovery in the ensuing weeks, so we’re going to put ONTX on extended watch.

Extended Watchlist:
AXXA, IMTV, HMNY, AREX, AYTU, IRBT, AVGR

Blue Horseshoe Stocks: SPY, CHFS & More

SPDR S&P 500 ETF (SPY)

We want to start things off today by looking to take advantage of the big rebound in the markets yesterday. When we want to play the markets as a whole, we generally look to the SPY options chain, and that’s what we’re going to do today as well.

We are seeing a significant gap up this morning, and are going to be looking for a classic dip-and-rip scenario due to profit taking. Our targets are going to be the SPY Weekly $264-266 Calls provided that support can hold above this morning’s premarket low of 263.56 on any pullbacks in order to remain interested.

CHF Solutions Inc. CHFS

We also want to highlight CHFS this morning as a possible bottom play. The stock is gapping up in the premarket past its 50DMA, and there is a massive gap on the chart to the upside from just under $5 to just under $8.

We’re going to put CHFS, which prior to today had already been approaching heavily oversold territory, on watch over the next few sessions for the possibility of a more sustained rebound.

Cronos Group, Inc. CRON

We’re getting a strong bottom bouncer signal from CRON as well this morning, and we wanted to highlight this chart also.

CRON is currently exhibiting most of the things we look for in a bottom play, and we’re excited to see where it could go in the near term, as it looks like there could be some serious upside here.

Extended Watchlist:
FNSR, INNT, SPOT, TOPS, FNJN, GMS, NETI, AYTU

Blue Horseshoe Stocks: LULU Recap & More

Lululemon Athletica Inc. LULU – Update

We signaled a range of calls in the LULU options chain in the wake of the company’s earnings beat yesterday morning, and we were met with some fantastic opportunities at huge single-session gains.

Every one of the five sets of contracts, the LULU Weekly $83-85 Calls, produced a shot at double-bag gains on the day, which were as follows:

$83 Calls – Range: 1.60-4.50 – Max Gain: 181%
$83.50 Calls – Range: 1.25-4.15 – Max Gain: 232%
$84 Calls – Range: 1.20-3.80– Max Gain: 217%
$84.50 Calls – Range: 1.00-2.90 – Max Gain: 190%
$85 Calls – Range: .82-3.24 – Max Gain: 295%

With such solid moves in just one day, LULU doesn’t owe us anything, but we’re still going to roll up our potential strike range and monitor the Weekly $85-86 Calls* as we finish out this short trading week.
_____

Fresh Options Idea:
Constellation Brands, Inc. STZ Weekly $222.50-230 Calls*

*Do NOT trade weekly calls on the last day of the week unless you are an expert level trader!

Elev8 Brands, Inc. VATE

As you can see from our commentary on the annotated chart below, we’re interested in the setup of the VATE chart at the moment. The stock just began to consolidate off of a sizable surge that had persisted for most of this month.

We’re going to put it on bottom watch, and look for an eventual rebound in the event it can maintain support at or above the .05-mark.

Extended Watchlist:
AYTU, AQMS, ESES, PTCT, CPRX, MARK, MYSZ. RAS

Blue Horseshoe Stocks: ENPH Review & More

Aytu BioScience, Inc. AYTU

We’ve done our best this week in reminding readers that our interest in AYTU was not a drill. Beginning from our initial alert in last Wednesday’s premarket report, the stock was exhibiting all the signs of a recovery play.

Yesterday we reiterated our interest for the second time this week, mentioning how the stock had already come a considerable distance from our observed low of .4118, and that it had picked up momentum on Monday, and that more gains could be in store.

We were right on the money as the stock extended its recent gains yesterday running to a new high of .76, which represents a five day swing of 85%

Enphase Energy, Inc. ENPH

Recently, we have had quite a few plays we’ve signaled within the past couple of months, exhibit really convincing, sustained uptrends, and ENPH is another one to put in that category.

While our most recent mention of the stock came on March 19th, in the midst of the current run as a reminder, our initial call came on February 28th. On that day, the stock saw a low of 3.07 and hasn’t looked back since.

Yesterday, ENPH surged to a new high of 5.58, marking a respectable one month run of 82% during which time volume has also been greatly increased.

Fresh Options Ideas – Both of the following are looking good today with untraded-upon earnings beats, so we’ve got a pair of fresh ideas to share this morning:

Lululemon Athletica Inc. LULU Weekly $83-85 Calls
Blackberry Ltd. BB Weekly $12.50 & $13 Calls

Extended Watchlist:
TOPS, ANW, IDXG, LHO, MARA

Blue Horseshoe Stocks: AYTU Update & More

Aytu BioScience, Inc. AYTU Yesterday morning, we were just discussing AYTU and the modest progress the stock had made since we flagged it as a bottom play in Wednesday’s premarket report. Not only had it displayed a cherry bottom setup, but we noted a string of insider buysat the time as well.Following that report, we would witness a low of .4118, and over the course of the ensuing four trading days, the stock has made a noteworthy move and continues to exhibit signs that more gains could be in store.

Yesterday it reached .61, which represents a run of 48% in under a week. It did so on record volume, so we’re definitely eager to see where the momentum could carry this play that was already on its way back up.

InspireMD, Inc. NSPR

NSPR has been in real trouble in 2018, losing ground at seemingly every turn and unable to get out of its own way. However, through a combination of a South American breakthrough announcement for two of the companies drugs, and being just plain oversold, we’re seeing a marginal premarket gap-up and will want to observe for a more sustained rebound.

The news was pertaining to NSPR receiving regulatory approval from the goverment of Peru for its CGuard™ Embolic Prevention System (EPS) and MGuard Prime™ products. Peru has a population of more than 30 million people. (>>View PR)

Extended Watchlist:
ARWR, GLOW, MDGS, MBRX, SEE, WBAI, LIQT, PIXY,